<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">HAV was identified as the etiologic agent of hepatitis A by Feinstone and colleagues 
 <xref rid="b0100" ref-type="bibr">[20]</xref> in 1973. Unlike HBV and HCV, which establish chronic infections in humans, HAV infection is usually acute and generates lifelong immunity. This condition is able to determine the disappearance of the virus in small and isolated populations 
 <xref rid="b0105" ref-type="bibr">[21]</xref>, 
 <xref rid="b0110" ref-type="bibr">[22]</xref> and did not probably favor its maintenance in early human communities. It is thus legitimate to wonder how HAV survived and evolved during early human history, a question that remains presently unanswered.
</p>
